Literature DB >> 16784869

Synthesis and biological evaluation of 5-arylamino-1H-benzo[d]imidazole-4,7-diones as inhibitor of endothelial cell proliferation.

Kwang-Hoe Chung1, Sung-Yu Hong, Hea-Jung You, Rae-Eun Park, Chung-Kyu Ryu.   

Abstract

5-Arylamino-1H-benzo[d]imidazole-4,7-diones were synthesized and tested for their inhibitory activities on the proliferation of human umbilical vein endothelial cells (HUVECs) and the smooth muscle cells (SMCs). Among them, several 1H-benzo[d]imidazole-4,7-diones exhibited the selective antiproliferative activity on the HUVECs. Further mechanistic study revealed that the inhibitory effect of one representative 1H-benzo[d]imidazole-4,7-dione 2b on HUVEC proliferation was mediated by the activation of p38 signaling pathway in the HUVECs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784869     DOI: 10.1016/j.bmc.2006.05.059

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Highly Active Small Aminated Quinolinequinones against Drug-Resistant Staphylococcus aureus and Candida albicans.

Authors:  Hatice Yıldırım; Nilüfer Bayrak; Mahmut Yıldız; Fatıma Nur Yılmaz; Emel Mataracı-Kara; Deepak Shilkar; Venkatesan Jayaprakash; Amaç Fatih TuYuN
Journal:  Molecules       Date:  2022-05-03       Impact factor: 4.927

2.  Cellular Mechanism of Newly Synthesized Indoledione Derivative-induced Immunological Death of Tumor Cell.

Authors:  Su-Jin Oh; Chung-Kyu Ryu; So-Young Baek; Hyunah Lee
Journal:  Immune Netw       Date:  2011-12-31       Impact factor: 6.303

3.  Synthesis and Structure-Activity Relationship Studies of Benzimidazole-4,7-dione-Based P2X3 Receptor Antagonists as Novel Anti-Nociceptive Agents.

Authors:  Jinsu Bae; Yeo-Ok Kim; Xuehao Han; Myung-Ha Yoon; Woong-Mo Kim; Yong-Chul Kim
Journal:  Molecules       Date:  2022-02-16       Impact factor: 4.411

4.  Imidazole as a Promising Medicinal Scaffold: Current Status and Future Direction.

Authors:  Sahar S Alghamdi; Rasha S Suliman; Khlood Almutairi; Khawla Kahtani; Dimah Aljatli
Journal:  Drug Des Devel Ther       Date:  2021-07-29       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.